Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.
Making the Case for Accelerated Withdrawal of Aducanumab.
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
Posttranslational modifications of a-tubulin in alzheimer disease.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Posttranslational modifications of a-tubulin in alzheimer disease.
Posttranslational modifications of a-tubulin in alzheimer disease. Transl Neurodegener. 2015; 4:9.
View in:
PubMed
authors with profiles
George Perry